nach oben

Canadian Journal of Anesthesia/Journal canadien d'anesthésie

Erschienen in:

26.10.2023 | Reports of Original Investigations

Ketamine sedation in the intensive care unit: a survey of Canadian intensivists

verfasst von: Sameer Sharif, MD, MSc, Laveena Munshi, MD, MSc, Lisa Burry, PharmD, Sangeeta Mehta, MD, Sara Gray, MD, Dipayan Chaudhuri, MD, MSc, Mark Duffett, PhD, Reed A. Siemieniuk, MD, PhD, Bram Rochwerg, MD, MSc

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We sought to understand the beliefs and practices of Canadian intensivists regarding their use of ketamine as a sedative in critically ill patients and to gauge their interest in a randomized controlled trial (RCT) examining its use in the intensive care unit (ICU).

Methods

We designed and validated an electronic self-administered survey examining the use of ketamine as a sedative infusion for ICU patients. We surveyed 400 physician members of the Canadian Critical Care Society (CCCS) via email between February and April 2022 and sent three reminders at two-week intervals. The survey was redistributed in January 2023 to improve the response rate.

Results

We received 87/400 (22%) completed questionnaires. Most respondents reported they rarely use ketamine as a continuous infusion for sedation or analgesia in the ICU (52/87, 58%). Physicians reported the following conditions would make them more likely to use ketamine: asthma exacerbation (73/87, 82%), tolerance to opioids (68/87, 77%), status epilepticus (44/87, 50%), and severe acute respiratory distress syndrome (33/87, 38%). Concern for side-effects that limited respondents’ use of ketamine include adverse psychotropic effects (61/87, 69%) and delirium (47/87, 53%). The majority of respondents agreed there is need for an RCT to evaluate ketamine as a sedative infusion in the ICU (62/87, 71%).

Conclusion

This survey of Canadian intensivists illustrates that use of ketamine as a continuous infusion for sedation is limited, and is at least partly driven by concerns of adverse psychotropic effects. Canadian physicians endorse the need for a trial investigating the safety and efficacy of ketamine as a sedative for critically ill patients.

Nur mit Berechtigung zugänglich

Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med 2014; 370: 444–54. https://doi.org/10.1056/nejmra1208705CrossRefPubMed

Stein-Parbury J, McKinley S. Patients' experiences of being in an intensive care unit: a select literature review. Am J Crit Care 2000; 9: 20–7.CrossRefPubMed

Hughes CG, McGrane S, Pandharipande PP. Sedation in the intensive care setting. Clin Pharmacol 2012; 4: 53–63. https://doi.org/10.2147/cpaa.s26582CrossRefPubMedPubMedCentral

Ragule CA, Wade KL, Rubino S. Update on the physiologic effects of ketamine in general anesthesia and spinal blockade: a review of the literature. AANA J 2019; 87: 489–94.PubMed

Siow WT, Tang SH, Agrawal RV, Tan AY, See KC. Essential ICU drug shortages for COVID-19: what can frontline clinicians do? Crit Care 2020; 24: 260. https://doi.org/10.1186/s13054-020-02971-xCrossRefPubMedPubMedCentral

Duprey MS, Dijkstra-Kersten SM, Zaal IJ, et al. Opioid use increases the risk of delirium in critically ill adults independently of pain. Am J Respir Crit Care Med 2021; 204: 566–72. https://doi.org/10.1164/rccm.202010-3794ocCrossRefPubMedPubMedCentral

Murray BP, Newsome AS. Opioids for sedation: has the pendulum swung too far? Am J Respir Crit Care Med 2021; 204: 611. https://doi.org/10.1164/rccm.202104-1012leCrossRefPubMedPubMedCentral

Wunsch H, Hill AD, Fu L, et al. New opioid use after invasive mechanical ventilation and hospital discharge. Am J Respir Crit Care Med 2020; 202: 568–75. https://doi.org/10.1164/rccm.201912-2503ocCrossRefPubMedPubMedCentral

Haas LE, Karakus A, Holman R, Cihangir S, Reidinga AC, de Keizer NF. Trends in hospital and intensive care admissions in the Netherlands attributable to the very elderly in an ageing population. Crit Care 2015; 19: 353. https://doi.org/10.1186/s13054-015-1061-zCrossRefPubMedPubMedCentral

10.

Kim JY, Kim JH, Yee J, Song SJ, Gwak HS. Risk factors of opioid-induced adverse reactions in elderly male outpatients of Korea Veterans Hospital. BMC Geriatr 2018; 18: 293. https://doi.org/10.1186/s12877-018-0990-1CrossRefPubMedPubMedCentral

11.

LimeSurvey GmbH. Welcome to LimeSurvey. The LifeSurvey. Available from URL: https://www.limesurvey.org (accessed June 2023).

12.

Burns KE, Duffett M, Kho ME, et al. A guide for the design and conduct of self-administered surveys of clinicians. CMAJ 2008; 179: 245–52. https://doi.org/10.1503/cmaj.080372CrossRefPubMedPubMedCentral

13.

Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health 2018; 6: 149. https://doi.org/10.3389/fpubh.2018.00149CrossRefPubMedPubMedCentral

14.

American Association of Public Opinion Research. Standard definitions: final dispositions of case codes and outcome rates for surveys. 2016. Available from URL: https://aapor.org/wp-content/uploads/2022/11/Standard-Definitions20169theditionfinal.pdf (accessed July 2023).

15.

Green SM, Roback MG, Krauss B, et al. Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department: an individual-patient data meta-analysis of 8,282 children. Ann Emerg Med 2009; 54: 158–68. https://doi.org/10.1016/j.annemergmed.2008.12.011CrossRefPubMed

16.

Newton A, Fitton L. Intravenous ketamine for adult procedural sedation in the emergency department: a prospective cohort study. Emerg Med J 2008; 25: 498–501. https://doi.org/10.1136/emj.2007.053421CrossRefPubMed

17.

Vardy JM, Dignon N, Mukherjee N, Sami DM, Balachandran G, Taylor S. Audit of the safety and effectiveness of ketamine for procedural sedation in the emergency department. Emerg Med J 2008; 25: 579–82. https://doi.org/10.1136/emj.2007.056200CrossRefPubMed

18.

Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med 2011; 57: 109–14. https://doi.org/10.1016/j.annemergmed.2010.09.010CrossRefPubMed

19.

Strayer RJ, Nelson LS. Adverse events associated with ketamine for procedural sedation in adults. Am J Emerg Med 2008; 26: 985–1028. https://doi.org/10.1016/j.ajem.2007.12.005CrossRefPubMed

20.

Buckland DM, Crowe RP, Cash RE, et al. Ketamine in the prehospital environment: a national survey of paramedics in the United States. Prehosp Disaster Med 2018; 33: 23–8. https://doi.org/10.1017/s1049023x17007142CrossRefPubMed

21.

Yuhalogarasan A, Barclay C, Verbeek PR. Low-dose ketamine in the prehospital setting. CMAJ 2022; 194: E171. https://doi.org/10.1503/cmaj.80599CrossRefPubMedPubMedCentral

22.

Kurdi MS, Theerth KA, Deva RS. Ketamine: current applications in anesthesia, pain, and critical care. Anesth Essays Res 2014; 8: 283–90. https://doi.org/10.4103/0259-1162.143110CrossRefPubMedPubMedCentral

23.

Hui C, Monteiro JP, Trivedi D, Vasant D, Carino G. Effect of ketamine on vasopressor needs in mechanically ventilated patients: a retrospective study. Brown K Hosp Med 2022; 1: 1–9. https://doi.org/10.56305/001c.36988CrossRef

24.

Shrestha GS, Shrestha N, Lamsal R, et al. Emergency intubation in Covid-19. N Engl J Med 2021; 384: e20. https://doi.org/10.1056/nejmvcm2007198CrossRefPubMed

25.

Ilg A BC, Shih J, Yankama T, Hayes Mm, Moskowitz A. Ketamine in critical care: exploring before and during COVID-19 attitudes and practices. Am J Respir Crit Care Med 2022; 205: A3556. Available from URL: https://www.atsjournals.org/https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3556 (accessed June 2023).

26.

Patel R, Samiee-Zafarghandy S, Ziesenitz V, et al. US drug shortages compared to the World Health Organization's model list of essential medicines for children: a cross-sectional study. Am J Health Syst Pharm 2022; 79: 2012–7. https://doi.org/10.1093/ajhp/zxac210CrossRefPubMed

27.

Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009; 180: 1092–7. https://doi.org/10.1164/rccm.200904-0537ocCrossRefPubMedPubMedCentral

28.

Luz M, Barreto BB, de Castro RE, et al. Practices in sedation, analgesia, mobilization, delirium, and sleep deprivation in adult intensive care units (SAMDS-ICU): an international survey before and during the COVID-19 pandemic. Ann Intensive Care 2022; 12: 9. https://doi.org/10.1186/s13613-022-00985-yCrossRefPubMedPubMedCentral

29.

Gershengorn HB, Wunsch H. Temporal trends and variability in ketamine use for mechanically ventilated adults in the United States. Ann Am Thorac Soc 2022; 19: 1534–42. https://doi.org/10.1513/annalsats.202112-1376ocCrossRefPubMed

30.

Kishimoto T, Chawla JM, Hagi K, et al. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med 2016; 46: 1459–72. https://doi.org/10.1017/s0033291716000064CrossRefPubMedPubMedCentral

31.

Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 2016; 17: 131–57. https://doi.org/10.1016/j.jpain.2015.12.008CrossRefPubMed

32.

Kraus C, Rabl U, Vanicek T, et al. Administration of ketamine for unipolar and bipolar depression. Int J Psychiatry Clin Pract 2017; 21: 2–12. https://doi.org/10.1080/13651501.2016.1254802CrossRefPubMed

33.

Perumal DK, Adhimoolam M, Selvaraj N, Lazarus SP, Mohammed MA. Midazolam premedication for Ketamine-induced emergence phenomenon: a prospective observational study. J Res Pharm Pract 2015; 4: 89–93. https://doi.org/10.4103/2279-042x.155758CrossRefPubMedPubMedCentral

34.

Groth CM, Droege CA, Connor KA, et al. Multicenter retrospective review of ketamine use in the ICU. Crit Care Explor 2022; 4: e0633. https://doi.org/10.1097/cce.0000000000000633CrossRefPubMedPubMedCentral

35.

Perbet S, Verdonk F, Godet T, et al. Low doses of ketamine reduce delirium but not opiate consumption in mechanically ventilated and sedated ICU patients: a randomised double-blind control trial. Anaesth Crit Care Pain Med 2018; 37: 589–95. https://doi.org/10.1016/j.accpm.2018.09.006CrossRefPubMed

36.

Baron R, Binder A, Biniek R, et al. Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015)—short version. Ger Med Sci 2015; 13: Doc19. https://doi.org/10.3205/000223CrossRefPubMedPubMedCentral

37.

Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018; 46: e825–73. https://doi.org/10.1097/ccm.0000000000003299CrossRefPubMed

38.

Canadian Medical Association. Critical care medicine profile. 2019. Available from URL: https://www.cma.ca/sites/default/files/2020-10/critical-care-e.pdf (accessed July 2023).

39.

Burns KEA, Moss M, Lorens E, et al. Wellness and coping of physicians who worked in ICUs during the pandemic: a multicenter cross-sectional North American survey. Crit Care Med 2022; 50: 1689–700.CrossRefPubMedPubMedCentral

40.

de Koning R, Egiz A, Kotecha J, et al. Survey fatigue Dduring the COVID-19 pandemic: an analysis of neurosurgery survey response rates. Front Surg 2021; 8: 690680. https://doi.org/10.3389/fsurg.2021.690680CrossRefPubMedPubMedCentral

Titel: Ketamine sedation in the intensive care unit: a survey of Canadian intensivists
verfasst von: Sameer Sharif, MD, MSc
Laveena Munshi, MD, MSc
Lisa Burry, PharmD
Sangeeta Mehta, MD
Sara Gray, MD
Dipayan Chaudhuri, MD, MSc
Mark Duffett, PhD
Reed A. Siemieniuk, MD, PhD
Bram Rochwerg, MD, MSc
Publikationsdatum: 26.10.2023
Verlag: Springer International Publishing
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 1/2024
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI: https://doi.org/10.1007/s12630-023-02608-x

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Ketamine sedation in the intensive care unit: a survey of Canadian intensivists